These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1178778)

  • 21. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of enteric microsphere of oleanolic acid dihemiphthalate sodium by salting-out action using spherical crystallization technique.
    Fan YL; Cui FD; Yang MS; Ji YB
    Yao Xue Xue Bao; 2005 Mar; 40(3):267-73. PubMed ID: 15952602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an oral rutin nanocrystal formulation.
    Mauludin R; Müller RH; Keck CM
    Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
    Ma Y; Li WZ; Chen DW
    Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of some factors affecting the in-vitro release of drug from prolonged release granulations. 1. Effect of method of preparation.
    Asker AF; Motawi AM; Abdel-Khalek MM
    Pharmazie; 1971 Mar; 26(3):170-2. PubMed ID: 5574493
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets.
    Nakagami H; Nada M
    Drug Des Deliv; 1991 Jul; 7(4):321-32. PubMed ID: 1930623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of compression pressure, drug particle size, drug form and test medium on the release of active ingredients from matrix tablets of a silicon base].
    Moldenhauer H; Kala H; Erbe S
    Pharmazie; 1975 Dec; 30(12):783-7. PubMed ID: 1219796
    [No Abstract]   [Full Text] [Related]  

  • 29. Tableting research and technology.
    Cooper J; Rees JE
    J Pharm Sci; 1972 Oct; 61(10):1511-55. PubMed ID: 4561201
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis and modeling of swelling and erosion behavior for pure HPMC tablet.
    Chirico S; Dalmoro A; Lamberti G; Russo G; Titomanlio G
    J Control Release; 2007 Sep; 122(2):181-8. PubMed ID: 17706830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral controlled release optimization of pellets prepared by extrusion-spheronization processing.
    Bianchini R; Vecchio C
    Farmaco; 1989 Jun; 44(6):645-54. PubMed ID: 2803450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrasion of tablets during scale-up: the influence of different crushing forces in laboratory and production perforated pan coaters.
    Mueller R; Kleinebudde P
    Eur J Pharm Biopharm; 2007 Sep; 67(2):458-63. PubMed ID: 17475452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of chitosan on the stability and morphological parameters of tablets with Epilobium parviflorum Schreb. extract.
    Marczyński Z; Bodek KH
    Polim Med; 2007; 37(3):3-11. PubMed ID: 18251200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R; Kala H; Richter M; Babel W; Sattler K
    Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral long-acting drugs. II. Tablets with soluble drug mixed with hardened castor oil].
    Starha L; Chalabala M
    Cesk Farm; 1969 Mar; 18(2):80-2. PubMed ID: 5779797
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components.
    Zgoda MM; Woskowicz M; Nachajski M; Haeusler O; Iwanczyk M
    Pharmazie; 2004 Aug; 59(8):651-3. PubMed ID: 15378860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
    Lu B; Wen R; Yang H; He Y
    Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.